People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emboline Inc | — | Other | Series C | $66.9M | $795.4M | 2020 |
| QuanDx, Inc. | — | Biotechnology | Seed | $4.3M | $133.2M | 2015 |
| Sentire Medical Systems, Inc. | — | Biotechnology | Seed | $1.8M | $2.5M | 2018 |
Peng Cheng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peng Cheng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| WILLIAM DAI | 1 | 8 |
| Amir Belson | 1 | 6 |
| J. Casey McGlynn | 1 | 5 |
| Elton Satusky | 1 | 4 |
| Guoliang Yu | 1 | 4 |
| Nicholas Pappas | 1 | 4 |
| David Krasne | 1 | 2 |
| Scott Russell | 1 | 2 |
| Jonathan Diamond | 1 | 2 |
| Eric Xiao | 1 | 1 |
| Issam Moussa | 1 | 1 |
| J. Casey D. McGlynn | 1 | 1 |
| Issam D. Moussa | 1 | 1 |
| Elton D. Satusky | 1 | 1 |
| Xiaojun Lei | 1 | 1 |
| Chunlin Liang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.